Optinose price target adjusted for stock split at Lake Street

Lake Street analyst Thomas Flaten lowered the firm’s

price target

on Optinose (

OPTN

) to $17 from $45 and keeps a Buy rating on the shares, saying that “in part accounting for the recent 1-for-15 reverse stock split, we revised our $3

price target

to $17″ after OptiNose delivered preliminary XHANCE revenue for Q4 of $22.4M, which was above the firm’s and consensus estimates.

Stay Ahead of the Market:

Published first on

TheFly

– the ultimate source for real-time, market-moving breaking financial news.

Try Now>>

See the top stocks recommended by analysts >>

Read More on OPTN: